Pfizer is recalling approximately 17,832 bags of 10% LMD in 5% Dextrose Injection (Dextran 40 in Dextrose Injection, USP). This prescription medication, used to increase blood volume, is being recalled because the IV bags have the potential to leak. A leaking bag can compromise the sterility of the medicine, which may lead to serious infections if the contaminated fluid is administered to a patient. This recall affects Hospira brand products distributed nationwide in the United States and Puerto Rico.
The integrity of the IV bag is compromised by leaks, which allows bacteria or other contaminants to enter the sterile fluid. If this non-sterile solution is injected into a patient's bloodstream, it could result in life-threatening systemic infections or other severe health complications.
Healthcare provider consultation and product return.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.